Company news

CVRx, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim

September 11, 2024

CVRx Announces Appointment of Two New Board Members

September 2, 2024

CVRx Announces Increased Inpatient Payment for Barostim Procedure

August 1, 2024

CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference

July 30, 2024

CVRx Reports Second Quarter 2024 Financial and Operating Results

July 28, 2024

CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024

July 14, 2024

CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer

June 24, 2024

CVRx to Present at the William Blair 44th Annual Growth Stock Conference

May 21, 2024

CVRx Announces Key Senior Leadership Team Hires

May 15, 2024

CVRx Reports First Quarter 2024 Financial and Operating Results

April 29, 2024

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

April 15, 2024

CVRx announces availability of additional data supporting long-term benefits of Barostim

April 14, 2024

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer

January 30, 2024

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

January 24, 2024

CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024

January 10, 2024

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans

January 7, 2024

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 26, 2023

CVRx receives FDA approval for expanded labeling of Barostim

December 25, 2023

CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference

November 14, 2023

CMS Increases Outpatient Payment for Barostim Procedure

November 2, 2023

CVRx Reports Third Quarter 2023 Financial and Operating Results

October 25, 2023

CVRx to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call on October 26th, 2023

October 11, 2023

CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference

July 26, 2023

CVRx Reports Second Quarter 2023 Financial and Operating Results

July 24, 2023

CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023

July 10, 2023

CVRx Set to Join Russell 2000 & 3000 Indexes

June 21, 2023

CVRx to Present at the William Blair 43rd Annual Growth Stock Conference

May 24, 2023

CVRx Reports First Quarter 2023 Financial and Operating Results

April 26, 2023

CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023

April 19, 2023

Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

March 20, 2023

CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call

March 15, 2023

CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial

February 20, 2023

CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

January 25, 2023

CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023

January 11, 2023

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results

January 8, 2023

CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 27, 2022

CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors

December 19, 2022

CVRx to Present at the Piper Sandler 34th Annual Healthcare Conference

November 15, 2022

CVRx to Attend Upcoming Investor Conferences

November 2, 2022

CVRx Launches new Barostim NEO2™ Implantable Pulse Generator

November 2, 2022

CVRx Reports Third Quarter 2022 Financial and Operating Results

October 31, 2022

CVRx to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call on November 1st, 2022

October 17, 2022

CVRx to Present at the Canaccord Genuity 42nd Annual Growth Conference

July 28, 2022

CVRx Reports Second Quarter 2022 Financial and Operating Results

July 27, 2022

CVRx to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call

July 13, 2022

CVRx Launches a new Barostim™ Programmer

July 11, 2022

CVRx to Present at the William Blair 42nd Annual Growth Stock Conference

May 22, 2022

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

May 8, 2022

CVRx Reports First Quarter 2022 Financial and Operating Results

April 24, 2022

CVRx to Report First Quarter 2022 Financial and Operating Results and Host Conference Call

April 11, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.